MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 1999

Primary Completion Date

June 30, 2002

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

docetaxel

DRUG

dofequidar fumarate

Trial Locations (3)

Centre Oscar Lambret, Lille

Institut Curie - Section Medicale, Paris

Haemato-Onkologische Praxis und Tagesklinik, Munich (Muenchen)

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK